Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00211484
What this trial is testing

Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.

Who this might be right for
Age-Related Macular Degenerations.Subfoveal Neovascularization.
Manhattan Eye, Ear & Throat Hospital 5
Not applicableLooking for participantsNCT06604104
What this trial is testing

Visual Frailty in Ageing

Who this might be right for
FrailtyAge-Related Macular DegenerationFunctional Status+5 more
University of Edinburgh 20
Not applicableLooking for participantsNCT07556406
What this trial is testing

Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study

Who this might be right for
Age-Related Macular DegenerationGeographic Atrophy
University of California, San Francisco 80
Not applicableEnded earlyNCT04270604
What this trial is testing

Biological Sample Collection for Research and Biobanking

Who this might be right for
Parkinson DiseaseDiabetes Mellitus, Type 1Macular Degeneration+4 more
New York Stem Cell Foundation Research Institute 1,279
Large-scale testing (Phase 3)Study completedNCT07389577
What this trial is testing

Compare JL14002 to Lucentis® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Jecho Biopharmaceuticals Co., Ltd. 443
Testing effectiveness (Phase 2)Study completedNCT00056823
What this trial is testing

Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Maculopathy
Genentech, Inc. 168
Not applicableLooking for participantsNCT05932069
What this trial is testing

Active AMD Study to Improve Function in Veterans

Who this might be right for
Age Related Macular Degeneration (AMD)
VA Office of Research and Development 70
Large-scale testing (Phase 3)Study completedNCT03930641
What this trial is testing

Study of the Safety of Brolucizumab 6 mg in Prefilled Syringe in Patients With Neovascular Age Related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Novartis Pharmaceuticals 34
Post-approval studies (Phase 4)Study completedNCT01810042
What this trial is testing

Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab

Who this might be right for
Exudative Age-related Macular Degeneration
Pusan National University Hospital 49
Early research (Phase 1)Active Not RecruitingNCT01736059
What this trial is testing

Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy

Who this might be right for
Non-exudative Age-related Macular DegenerationDiabetic RetinopathyRetina Vein Occlusion+2 more
University of California, Davis 15
Large-scale testing (Phase 3)Study completedNCT01783886
What this trial is testing

Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement

Who this might be right for
Macular Edema
Bayer 381
Not applicableUnknownNCT00893724
What this trial is testing

Supplemental Adjuvants for Intracellular Nutrition and Treatment

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Mid-Atlantic Retina Consultations, Inc. 60
Post-approval studies (Phase 4)Study completedNCT02142296
What this trial is testing

Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)

Who this might be right for
Retinal Pigment Epithelial Detachment Secondary to Age-related Macular Degeneration
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 37
Not applicableStudy completedNCT07074054
What this trial is testing

Aflibercept 8 mg for nAMD: Early Anatomical and Functional Changes

Who this might be right for
Presence of Retinal FluidChanges in Macular Pigment Optical Density
Federico II University 40
Post-approval studies (Phase 4)Study completedNCT00473642
What this trial is testing

Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration

Who this might be right for
Age-Related MaculopathyChoroidal Neovascularization
Oklahoma State University Center for Health Sciences 31
Not applicableLooking for participantsNCT06489873
What this trial is testing

Lutein, Zeaxathin, and Fish Oil Supplementation

Who this might be right for
Cognitive PerformanceAge-Related Macular DegenerationBone Loss
Texas A&M University 80
Large-scale testing (Phase 3)Study completedNCT03917472
What this trial is testing

Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 517
Not applicableStudy completedNCT05542381
What this trial is testing

The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain

Who this might be right for
Age-Related Macular Degeneration
Virginia Polytechnic Institute and State University 64
Not applicableStudy completedNCT02367365
What this trial is testing

Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Duke University 75
Post-approval studies (Phase 4)Ended earlyNCT00327470
What this trial is testing

An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD

Who this might be right for
Age Related Macular Degeneration (AMD)Macular DegenerationChoroidal Neovascularization (CNV)
Pfizer 288
Next Page